Strategic Partners
The ICATI Advisory Group is comprised of key organizations that observe and provide feedback on the strategic development, priorities, and direction of the Consortium.
U.S. Department of State's Bureau of International Narcotics and Law Enforcement (INL)
INL works to keep Americans safe at home by countering international crime, illegal drugs, and instability abroad. INL helps countries deliver justice and fairness by strengthening their police, courts, and corrections systems. These efforts reduce the amount of crime and illegal drugs reaching U.S. shores.
Colombo Plan / Drug Advisory Programme (DAP)
DAP is part of the Colombo Plan and is the only regional intergovernmental programme exclusively aimed at capacity building for drug demand reduction in the Asia and Pacific Region. During the last three decades the DAP has assisted member counties in initiating the process of policy evolution, in finding appropriate solutions on a bilateral and/or multi-lateral basis and in encouraging national efforts among member countries towards drug demand reduction.
Organization of American States (OAS) / CICAD
Within OAS the Inter-American Drug Abuse Control Commission (CICAD) is the Western Hemisphere's policy forum for dealing with the drug problem. The CICAD Executive Secretariat supports the Commission by strengthening the human and institutional capabilities and channeling the collective efforts of its member states to reduce the production, trafficking and use of illegal drugs.
United Nations Office on Drugs and Crime (UNODC)
UNODC is mandated to assist Member States in addressing the issues of drugs, crime and terrorism. Working in cooperation with our partners and through our network of field offices, UNODC helps Member States facing urgent problems including smuggling of migrants and trafficking in persons, wildlife crime, maritime crime, cybercrime and trafficking in illicit drugs, firearms and cultural property. Further, UNODC seeks to combat corruption, reinforce efforts to prevent and counter terrorism, and enhance alternative development and access to controlled substances for medical purposes, promote evidence-based approaches to drug use prevention, treatment and rehabilitation, as well as HIV and AIDS.
